IP Library Granted Patent US 11,617,817
Granted Patent B2
US 11,617,817 · App. 16/589,768 · Granted Apr 4, 2023

Biomaterials for enhanced implant-host integration

Inventors: Christopher S. Chen (Princeton, NJ); Jan D. Baranski (Philadelphia, PA); Ritika Chaturvedi (Philadelphia, PA); Michael T. Yang (West Windsor, NJ); Kelly Stevens (Seattle, WA); Sangeeta Bhatia (Lexington, MA)
Assignees: The Trustees of the University of Pennsylvania; Massachusetts Institute of Technology
A61L27/50A61K35/44A61L27/225A61L27/24A61L27/3604A61L27/3804A61L27/3808A61L27/3834A61L27/3839A61L27/3886A61L27/40A61L27/507A61L2430/20A61L2430/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,617,817
App. No.
16/589,768
Granted
Apr 4, 2023
Kind
B2
Abstract

The present disclosure provides patterned biomaterials having organized cords and extracellular matrix embedded in a 3D scaffold. According, the present disclosure provides compositions and applications for patterned biomaterials. Pre-patterning of these biomaterials can lead to enhanced integration of these materials into host organisms, providing a strategy for enhancing the viability of engineered tissues by promoting vascularization.

Claims (19)

1. A patterned biomaterial for implantation in a subject comprising at least one cord, formed by embedding cells in a naturally-derived or synthetic scaffolding with a pre-specified architecture and spatially organizing the cells within the scaffolding, wherein the at least one cord comprises endothelial cells, wherein the structure of the patterned biomaterial has a pre-specified architecture that acts as a template and spatial guidance for a subject's vasculature to invade and integrate at least partially within the at least one cord upon implantation.

2. The patterned biomaterial of claim 1 , further comprising an extracellular matrix or a physically solid scaffold at least partially encapsulating the at least one cord.

3. The patterned biomaterial of claim 2 , wherein the extracellular matrix scaffold comprises fibrin.

4. The patterned biomaterial of claim 2 , wherein the extracellular matrix scaffold further comprises at least one cell type.

5. The patterned biomaterial of claim 4 , wherein the at least one cell type comprises hepatocytes, endothelial cells, mesenchymal stem cells, or a combination thereof.

6. The patterned biomaterial of claim 4 , wherein the at least one cell type comprises endothelial cells.

7. The patterned biomaterial of claim 1 , wherein the naturally-derived or synthetic scaffolding comprises collagen.

8. The patterned biomaterial of claim 1 , wherein the at least one chord is branched.

9. The patterned biomaterial of claim 1 , wherein the at least one chord comprises a plurality of chords.

10. The patterned biomaterial of claim 9 , wherein the plurality of cords are formed in a parallel arrangement within the naturally-derived or synthetic scaffolding.

11. The patterned biomaterial of claim 9 , wherein the plurality of cords are formed in a nonparallel arrangement within the naturally-derived or synthetic scaffolding.

12. The patterned biomaterial of claim 1 , wherein the at least one cord is cylindrical, Y-shaped, or T-shaped.

13. The patterned biomaterial of claim 1 , wherein the at least one cord is solid or hollow in cross-section.

14. The patterned biomaterial of claim 1 , further comprising at least one cluster of cells.

15. The patterned biomaterial of claim 14 , wherein the at least one cluster of cells comprises hepatocytes, endothelial cells, mesenchymal stem cells, or a combination thereof.

16. An ex vivo patterned biomaterial for implantation in a subject, comprising one or more endothelial cell cords, wherein the one or more cords is at least partially embedded in a naturally-derived or synthetic scaffolding, wherein the structure of the patterned biomaterial has a pre-specified architecture that acts as a template and spatial guidance for a subject's vasculature to invade and integrate at least partially within the one or more endothelial cell cords upon implantation.

17. The ex vivo patterned biomaterial of claim 16 , wherein the scaffolding is a naturally-derived scaffolding.

18. The ex vivo patterned biomaterial of claim 16 , wherein the scaffolding is a synthetic scaffolding.

19. A patterned biomaterial post-implantation in a subject, comprising one or more endothelial cell cords, wherein the one or more cords is at least partially embedded in a naturally-derived or synthetic scaffolding, and wherein the subject's vasculature has invaded and integrated at least partially within the one or more endothelial cell cords.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 8, 2023
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064852/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2021
From: CHEN, CHRISTOPHER S.; BARANSKI, JAN D.; YANG, MICHAEL T.; CHATURVEDI, RITIKA
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 055348/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2021
From: STEVENS, KELLY; BHATIA, SANGEETA
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 055348/0546 →
Continuity (4)
Division 14593555 · Jan 9, 2015
Continuation PCTUS2013049933 · Jul 10, 2013
Provisional Application 61670100 · Jul 10, 2012
Related Publication 20200101201A1 · Apr 2, 2020
Cited By (1)
US 12,642,890